iPLEDGE Weaknesses: Is It Time to Address the Flaws?

被引:0
|
作者
Cyrulnik, Amanda A. [1 ,2 ]
Gewirtzman, Aron J. [1 ,3 ]
Paz, Karin Blecher [1 ]
Glick, Jaimie B. [2 ]
Anam, Anika K. [2 ]
Carrasco, Daniel A. [3 ]
Shalita, Alan R. [2 ]
Cohen, Steven R. [1 ]
机构
[1] Albert Einstein Coll Med, Unified Div Dermatol, Bronx, NY 10467 USA
[2] SUNY Downstate Dept Dermatol, Brooklyn, NY USA
[3] Austin Dermatol Associates, Austin, TX USA
关键词
ELECTRONIC MEDICAL-RECORD; ISOTRETINOIN;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The observance during acne follow-ups that information stored within iPLEDGE was discordant with medical charts prompted this study. Objective: To evaluate the information acquired and stored within iPLEDGE as it compares to medical charts with a goal of assessing the efficacy of iPLEDGE as a database. Methods: This is a multicenter retrospective chart review analyzing congruence and discrepancies between medical chart documentation and iPLEDGE data for all patients who received at least a single dose of isotretinoin from the primary investigators between January 2006 and November 2010. Results: A total of 357 charts were analyzed. Overall congruence between medical chart documentation and iPLEDGE data was observed in only 73.1 % of cases. The discrepancy (N=96) was due to a missed dose (prescription recorded in chart but not in iPLEDGE) in 81.4% of cases, or an addition (medication dispensed per iPLEDGE without corresponding chart documentation) in the remainder of cases. Of note, several charts had multiple discrepancies (N=249 total discrepancies). Limitations: Retrospective chart review study. Conclusion: Given the large percentage of discordant data, our findings question the efficacy of the iPLEDGE system, which is designed to monitor every dispensed isotretinoin dose.
引用
收藏
页码:97 / 102
页数:6
相关论文
共 50 条
  • [1] iPledge registry weaknesses: It is time to address the flaws?
    Cyrulnik, Amanda
    Gewirtzman, Aron
    Blecher, Karin
    Viola, Kate
    Cohen, Steven
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB16 - AB16
  • [2] The Strengths and Weaknesses of Crowds to Address Global Problems
    Broomell, Stephen B.
    Davis-Stober, Clintin P.
    PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, 2024, 19 (02) : 465 - 476
  • [3] The Strengths and Weaknesses of Current US Policy to Address Pain
    Gross, Jacob
    Gordon, Debra B.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2019, 109 (01) : 66 - 72
  • [6] Strengths and weaknesses of existing data sources to support research to address the opioids crisis
    Smart, Rosanna
    Kase, Courtney A.
    Taylor, Erin A.
    Lumsden, Susan
    Smith, Scott R.
    Stein, Bradley D.
    PREVENTIVE MEDICINE REPORTS, 2020, 17
  • [7] Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE
    Barbieri, John S.
    Frieden, Ilona J.
    Nagler, Arielle R.
    JAMA DERMATOLOGY, 2020, 156 (01) : 21 - 22
  • [8] Time, temperature, and load: The flaws of carbon nanotubes
    Ruoff, RS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (18) : 6779 - 6780
  • [9] Detecting and preventing type flaws at static time
    Bodei, Chiara
    Brodo, Linda
    Degano, Pierpaolo
    Gao, Han
    JOURNAL OF COMPUTER SECURITY, 2010, 18 (02) : 229 - 264
  • [10] Longer Rodent Bioassay Fails to Address 2-Year Bioassay's Flaws
    Manuppello, Joseph
    Willett, Catherine
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2008, 116 (12) : A516 - A517